Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Zenotech Labs Gets U.S. FDA Approval for Ondansetron Injection

Sept. 26 (Bloomberg) -- Zenotech Laboratories Ltd., an Indian drugmaker, received approval from the U.S. Food and Drug Administration for its ondansetron injection, a copy of Glaxosmithkline Plc.’s Zofran anti-nausea medicine, according to a statement on the regulator’s website.

Link to Company News:{3400398Z US <Equity> CN <GO>} Link to Company News:{4568 JP <Equity> CN <GO>} Link to Company News:{GSK LN <Equity> CN <GO>} Link to Company News:{RBXY IN <Equity> CN <GO>} Link to Company News:{ZTL IN <Equity> CN <GO>}

To contact the reporter on this story: Adi Narayan in Mumbai at anarayan8@bloomberg.net

To contact the editor responsible for this story: Pradeep Kurup at pkurup3@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.